The ICTR continues to be a key source of support for translational research across Johns Hopkins. Our research ecosystem provides a strong, nimble infrastructure allowing support for translational research from study design to data analysis.
Grant Recipients and Awardees
Accelerated Translational Incubator Pilot Program (ATIP) Recipients
Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) K12 Award Recipients
Community Partnership and Collaboration Core Pilot Grant Recipients
Doris Duke Early Clinician Investigator Awardees
Johns Hopkins and Kaiser Permanente Research Collaboration Committee Awardees
Featured Publications
Jaffray, J., Mosha, M., Branchford, B., Goldenberg, N. A., Silvey, M., Croteau, S. E., Fargo, J. H., Cooper, J. D., Bakeer, N., Stillings, A., Krava, E., Young, G., & Amankwah, E. K. (2023). Corrigendum to ‘Evaluation of Venous Thromboembolism Risk Factors Reveals Subtype Heterogenicity in Children with Central Venous Catheters: A Multi-Center Study from the CHAT Consortium’ [Journal of Thrombosis and Haemostasis 21/9 (2023) 2441 – 2450]. Journal of thrombosis and haemostasis : JTH, S1538-7836(23)00703-1. Advance online publication. https://doi.org/10.1016/j.jtha.2023.09.005
Enoxaparin Thromboprophylaxis in Children Hospitalized for COVID-19: A Phase 2 Trial
Sochet, A. A., Morrison, J. M., Jaffray, J., Godiwala, N., Wilson, H. P., Thornburg, C. D., Bhat, R. V., Zia, A., Lawrence, C., Kudchadkar, S. R., Hamblin, F., Russell, C. J., Streiff, M. B., Spyropoulos, A. C., Amankwah, E. K., Goldenberg, N. A., & COVID-19 Anticoagulation in Children – Thromboprophylaxis (COVAC-TP) Trial Investigators (2022). Enoxaparin Thromboprophylaxis in Children Hospitalized for COVID-19: A Phase 2 Trial. Pediatrics, 150(1), e2022056726. https://doi.org/10.1542/peds.2022-056726
Where to Retire? Experiences of Older African Immigrants in the United States
Nkimbeng, M., Akumbom, A., Granbom, M., Szanton, S. L., Shippee, T. P., Thorpe, R. J., & Gaugler, J. E. (2022). Where to Retire? Experiences of Older African Immigrants in the United States. International Journal of Environmental Research and Public Health, 19(3), [1040]. https://doi.org/10.3390/ijerph19031040
JAMA Publishes Practice-Changing Findings of JHACH-Led, NIH-Funded, Randomized Clinical
Goldenberg NA, Kittelson JM, Abshire TC, et al. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial. JAMA. 2022;327(2):129–137. doi:10.1001/jama.2021.23182
